Sublingual Immunotherapy for Respiratory Allergy
European Respiratory & Pulmonary Diseases · 2015
DOI: 10.17925/erpd.2015.01.01.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory & Pulmonary Diseases, 2015. Verfasst von Moises A Calderon.
Abstract (Originalsprache)
Sublingual allergen immunotherapy (SLIT) is a new alternative for the treatment of respiratory allergy. Strong evidence-based medicine data on clinical efficacy and safety about SLIT support the new standardised products register in Europe and the US. SLIT-tablets significantly reduce nasal and ocular symptoms scores, reduce the use of relief medication and improves quality of life in both adults and children with pollen respiratory allergy. New data support its efficacy and safety for house dust mites (HDM) respiratory allergy.
Zitieren
APA
Calderon, M. A. (2015). Sublingual Immunotherapy for Respiratory Allergy. European Respiratory & Pulmonary Diseases. https://doi.org/10.17925/erpd.2015.01.01.25
Vancouver
Calderon MA. Sublingual Immunotherapy for Respiratory Allergy. European Respiratory & Pulmonary Diseases. 2015. doi:10.17925/erpd.2015.01.01.25
BibTeX
@article{Calderon2015,
author = {Calderon, Moises A},
title = {Sublingual Immunotherapy for Respiratory Allergy},
journal = {European Respiratory & Pulmonary Diseases},
year = {2015},
doi = {10.17925/erpd.2015.01.01.25}
}
EUVIMED